Our Solutions   Nab Paclitero 100 mg Injection

Nab Paclitero 100 mg Injection

Nab Paclitero 100Mg Injection

*To be consumed as directed by physician.

Therapies:

Anti Neoplastics

Composition:

Paclitaxel IP 100 mg, Human Albumin IP (Lyophilised)

About Nab Paclitero 100Mg Injection

Nab Paclitero 100 mg Injection contains Paclitaxel 100 mg, an anticancer medicine belonging to the taxane class of chemotherapy drugs. It is indicated for the treatment of breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer, either alone or in combination with other anticancer medicines. Paclitaxel works by disrupting the microtubule structures required for cancer cell division, thereby slowing the growth and spread of cancer cells and ultimately causing their destruction. Nab Paclitero should be administered only under the supervision of an experienced oncology specialist.

Nab Paclitero 100Mg Injection

*To be consumed as directed by physician.


Usage Instructions

  • Nab Paclitero 100 mg Injection should only be administered by a qualified healthcare professional.
  • The dosage, frequency, and duration of treatment depend on the type and stage of cancer, body surface area, overall health, and response to therapy.
  • Regular blood tests may be required to monitor blood cell counts, liver function, and overall treatment response.
  • Do not miss scheduled treatment sessions or discontinue therapy unless advised by your oncologist.
  • Supportive medicines may be prescribed to help manage treatment-related side effects.

    • Benefits and Use

  • Nab Paclitero 100 mg Injection is used in the treatment of breast cancer, non-small cell lung cancer, and pancreatic cancer.
  • It works by preventing cancer cells from dividing and multiplying, thereby slowing tumour growth and helping destroy cancer cells.
  • When used alone or in combination with other chemotherapy agents, it helps control disease progression, improves treatment outcomes, and may relieve cancer-related symptoms while supporting long-term disease management under specialist supervision.

    • Safety Information

  • Pregnancy:
  • Do not use during pregnancy, as Paclitaxel can cause serious harm to the unborn baby. Effective contraception should be used by both men and women during treatment and for the period recommended by your doctor after therapy.
  • Breastfeeding:
  • Breastfeeding is not recommended during treatment due to the risk of serious harm to the infant.
  • Alcohol:
  • Consult your doctor before consuming alcohol during therapy.
  • Kidney Disorders:
  • Use with caution in patients with kidney disease; dose adjustments and monitoring may be required.
  • Liver Disorders:
  • Use cautiously in patients with liver impairment and avoid use in severe liver disease unless specifically recommended by your oncologist.
  • Driving:
  • The medicine may cause dizziness, drowsiness, or visual disturbances. Avoid driving or operating machinery if affected.
  • Blood Cell Monitoring:
  • Paclitaxel may reduce red blood cells, white blood cells, and platelets, increasing the risk of infections and bleeding.
  • Inform your doctor immediately if you develop fever, sore throat, mouth ulcers, unusual bruising, bleeding, persistent diarrhea, numbness or tingling in the hands or feet, swelling, or sudden weight gain.

    • Ingredients

    Paclitaxel IP 100 mg, Human Albumin IP (Lyophilised)

    How to Use

  • Nab Paclitero 100 mg Injection is administered as an intravenous (IV) infusion by a doctor or trained healthcare professional, usually according to your prescribed chemotherapy schedule.
  • Do not self-administer.
  • Follow all medical instructions regarding hydration, blood tests, and supportive medications throughout treatment.

    • Storage Information

  • Store below 30°C in the original packaging, protected from light and moisture.
  • Do not freeze.